Charles David Pauza - Oct 12, 2025 Form 4 Insider Report for Traws Pharma, Inc. (TRAW)

Role
Chief Science Officer Virology
Signature
/s/ Charles David Pauza
Stock symbol
TRAW
Transactions as of
Oct 12, 2025
Transactions value $
$0
Form type
4
Date filed
10/15/2025, 08:08 PM
Previous filing
Apr 3, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pauza Charles David Chief Science Officer Virology C/O TRAWS PHARMA, INC., 12 PENNS TRAIL, NEWTOWN /s/ Charles David Pauza 2025-10-15 0002018150

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRAW Stock Option (right to purchase) Award $0 +32.4K $0.00 32.4K Oct 12, 2025 Common Stock 32.4K $3.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest 100% on the first anniversary of the grant date.